These findings are in good agreement with the TRPM7, ORAI1, and STIM1 inhibition data showing their effect on hyper-O-GlcNAcylation, and with the clinical data linking hypo-O-GlcNAcylation with aggressive MM. The gene discussed is ORAI1; the disease is Miyoshi myopathy.